Medscape Nets $17.3 Million Through Private Investors
The new year is already proving profitable for Medscape (formerly Medicalogic/Medscape), which has begun referring to itself as a provider of digital health record technologies (versus EMRs) and online health information. The company has signed a
The new year is already proving profitable for Medscape (formerly Medicalogic/Medscape), which has begun referring to itself as a provider of digital health record technologies (versus EMRs) and online health information. The company has signed a definitive agreement with a group of investors for a $17.3 million capital investment. The financing involves issuing 5.7 million shares of preferred stock at $3 per share, with warrants to purchase 4.4 million shares of common stock at $0.01 per share. The deal coincides with the appointment of Donald Bloodworth as Medscape's chief financial officer.
In related news, Medscape has signed its first digital health agreement, with Glaxo Wellcome. The educational initiative will create asthma-specific sites and disease management tools on medscape.com and cbshealthwatch.com, two Web sites produced by Medscape.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
